Janet Gilbert
Family Medicine · Kearney, MONPI 1386793602
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $772 and has fallen 63.9% since, to $279 in 2025.
Across 134 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$558
- Abbott$235
- AbbVie$227
- Mylan Specialty L.p.$201
- Teva Pharmaceuticals USA, Inc.$147
- Kowa Pharmaceuticals America, Inc.$145
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $558 |
| Abbott | 6 | $235 |
| AbbVie(2 entities) | 9 | $227 |
| Mylan Specialty L.p. | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. | 8 | $147 |
| Kowa Pharmaceuticals America, Inc. | 10 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $116 |
| Boehringer Ingelheim | 6 | $114 |
| Endo Pharmaceuticals Inc. | 4 | $71 |
| Astellas Pharma US Inc | 3 | $70 |
| Pfizer | 4 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Amgen(2 entities) | 3 | $52 |
| Merck | 3 | $47 |
| Corium, LLC | 2 | $46 |
| Genentech USA, Inc. | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $37 |
| Eisai Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Scynexis, Inc. | 2 | $29 |
| Clarus Therapeutics Inc. | 2 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Dermira, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Vistapharm, Inc. | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$155
- MOUNJARO$103
How this compares
$2,645 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $731 |
| Morphine Sulfate | 12 | $343 |
| Pregabalin | 12 | $212 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $166 |
| Oxycodone Hcl | 11 | $79 |
| Alprazolam | 22 | $67 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kearney
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.